The Asia Pacific Implantable Loop Recorders Market would witness market growth of 13.2% CAGR during the forecast period (2020-2026).
The ILR is the first phase in what should be a growing area of long-term physiological monitoring devices. The development of new sensors that could be used to measure blood pressure or blood volume would continue to provide details on the syncope mechanism. Continued sensor technology would potentially include commercial products capable of measuring blood pressure, cholesterol, oxygen saturation, and brain function, as well as other physiological parameters.
These innovative opportunities will include better tools for tracking patients with a range of disabilities in the "real world" outpatient setting. In addition to the assumption that existing external tracking systems are capable of being activated by patients, both patients will be offered the option of an auto-triggering incident monitor with more regular symptoms of ILR reserved for more unusual symptoms. The ILR has emerged as a secure and efficient method to monitor patients suffering from chronic unexplained syncope. In addition, it is possible to track atrial fibrillation and to classify the etiology of palpitations.
Increased incidence of cardiac problems, the technical innovation of cardiac monitors, and demand for remote patient tracking are increasing the market for implantable loop recorders. In addition, physical inactivity related to a sedentary lifestyle raises the likelihood of having chronic cardiac conditions, which are anticipated to fuel the need for cardiovascular care and self-monitoring.
Based on Application, the market is segmented into Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope. Based on End User, the market is segmented into Hospitals, Cardiac Centers and Other End Users. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Angel Medical Systems, Inc., and Vectorious Medical Technolgoies Ltd.
Scope of the Study
- Atrial fibrillation
- Cardiac Arrhythmia and
- Cardiac syncope
By End User
- Cardiac Centers
- Other End Users
- South Korea
- Rest of Asia Pacific
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Angel Medical Systems, Inc.
- Vectorious Medical Technolgoies Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free